ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
AstraZeneca
The Portfolio Analytics Lead at Alexion, AstraZeneca Rare Disease will drive revenue forecasting, long‑term portfolio planning, and strategic financial analysis for early commercial pipeline indications. The role partners with senior leaders across global functions to develop business cases, scenario models, and insights that inform executive decision‑making and portfolio prioritization.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
15% below the average for this role
Associate Director, Brand Analytics – Rare Disease (RD)
Sanofi
Sr. Director, Portfolio Strategy and Analytics | Onsite San Diego HQ
lifelancer
Director, Insights and Analytics
Dyne Therapeutics
R&D Portfolio Intelligence & Analytics Lead
Syngenta Group
Portfolio Analytics Manager
mjkconnections
CD&A - Senior Director, US Forecasting, Rare Disease
Amgen